Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMINENCE
PACTR202605878416520Phase 3Not yet recruiting
- Sponsor
- Higher Institute of Scientific and Medical Research
- Start
- Jun 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of moxidectin and ivermectin in onchocerciasis (3 arms), sponsored by Higher Institute of Scientific and Medical Research. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
moxidectinivermectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on PACTR202605878416520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605878416520.